Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Pelthos Therapeutics Inc., a biopharmaceutical company specializing in cutaneous infectious disease treatments, will report its second quarter 2026 financial results on August 13, 2026, followed by a conference call for investors and analysts. The company focuses on commercializing innovative topical therapies addressing unmet patient needs, includ…
eGain Corporation, recognized as a leader in Gartner's Magic Quadrant for Customer Service Knowledge Management Systems, presented its approach to AI governance emphasizing the importance of an accurate and governed knowledge layer, termed AI KnowledgeOps. Addressing recent AI containment breaches highlighted by OpenAI and Anthropic, eGain position…
Akebia Therapeutics announced the initiation of a Phase 2 basket trial evaluating ebribafusp, a novel complement inhibitor designed to treat rare kidney diseases such as IgA nephropathy, lupus nephritis, and C3 glomerulopathy. The trial aims to demonstrate safety, efficacy, and pharmacokinetics through weekly subcutaneous dosing over 26 weeks, with…
AgEagle Aerial Systems, traded as EagleNXT (NYSE: UAVS), announced the hiring of Lindsay A. Ryan, a 21-year U.S. Army aviation veteran, as Head of Sales and Business Development for their Counter-Unmanned Aircraft Systems (C-UAS) division. Ryan's extensive military experience and leadership in aviation are expected to drive sales growth and expand …
CytomX Therapeutics announced the appointment of Alejandra Carvajal as Chief Legal Officer. With over 20 years of legal expertise in biotech, Ms. Carvajal will aid in the company's strategic and operational initiatives as CytomX advances its oncology-focused PROBODY therapeutic pipeline. The company is focused on conditionally activated biologics f…
Shoals Technologies Group announced a strategic memorandum of understanding with TerraFlow Energy to collaborate on developing and deploying up to 5 GW annually of grid-scale long-duration energy storage, combining TerraFlow's vanadium flow battery technology with Shoals' power distribution systems for utility-scale and data center applications. Th…
Anavex Life Sciences Corp. disclosed plans to refresh its board with two new independent directors possessing deep life sciences and regulatory expertise. The company has established an Executive Committee to manage its business and emphasized focus on advancing its lead Alzheimer's candidate, oral blarcamesine (ANAVEX®2-73), across multiple CNS in…
Altimmune, Inc. has initiated enrollment in the PERFORMA global Phase 3 clinical trial to evaluate the efficacy and safety of its lead drug candidate, pemvidutide, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced fibrosis. Building on positive Phase 2b IMPACT trial data demonstrating significant MASH…
KellyOCG, the outsourcing and consulting division of Kelly Services, has been named a global and U.S. leader in Everest Group's 2026 Recruitment Process Outsourcing (RPO) Services PEAK Matrix. This accolade reflects KellyOCG's integrated and scalable talent acquisition services supported by AI-powered technology such as its Sevayo platform and cons…
VirTra, Inc., a global provider of use-of-force and firearms training simulators, will hold its second quarter 2026 earnings conference call on August 13, 2026, to discuss financial results for the period ended June 30, 2026. The company will issue a press release prior to the call, followed by a management presentation and Q&A session. This event …
GSI Technology, an innovator in Associative Processing Unit technology for AI and high-performance computing, announced its participation in the Needham Virtual Semiconductor & SemiCap Conference on August 19-20, 2026. Company executives will hold one-on-one meetings with institutional investors during the event to discuss their scalable, low-power…
Freedom Metals Acquisition Corp., a blank check company focused on mergers in the mining and critical minerals industry, announced that its Class A Ordinary Shares and Warrants will begin separate trading on Nasdaq starting August 4, 2026. Previously trading as combined units, shareholders can now trade shares under ticker FDMM and warrants under F…
Powerus, through its subsidiary Tandem Defense, has secured a competitively awarded indefinite-delivery/indefinite-quantity contract from the U.S. Air Force with a ceiling value of up to $90 million through mid-2028. The contract covers Group 1 aerial-denial unmanned aircraft systems, including equipment, training, and field service support. This a…
Taysha Gene Therapies and Catalent have expanded their partnership to include commercial manufacturing support for Taysha's investigational gene therapy TSHA-102 targeting Rett syndrome. The agreement ensures long-term commercial manufacturing capacity at Catalent's FDA-licensed facility, supporting a potential U.S. launch pending FDA approval. Thi…
The U.S. State Department is formalizing a visa bond requirement for citizens of 50 countries applying for B1 and B2 visas, allowing consular officers to demand bonds of up to $20,000. The decision follows a 2025 pilot and is presented as a tool to curb visa overstays; critics say it will discourage legitimate travel and raise barriers to legal ent…
Microsoft shares climbed in pre-open trading after a fiscal 2026 fourth-quarter report that beat expectations. The company reported $90 billion in revenue, a 18% year-over-year gain, with Azure revenue up 43% and crossing $100 billion in annual revenue. A rapidly expanding commercial order backlog and upgraded analyst views have bolstered investor …
U.S. stock futures climbed on Monday after President Donald Trump said talks with Iran would begin this week, easing recent geopolitical tensions and bolstering risk appetite. Technology names attempted to recover following a steep July pullback. In premarket action, Supernus Pharmaceuticals jumped on a merger announcement with Indivior, Ferguson r…
Latigo Biotherapeutics Inc. has filed to raise up to $288 million in an initial public offering, proposing 16 million shares priced between $16 and $18. The clinical-stage company, which develops non-opioid pain treatments and is backed by Blue Owl Capital Inc., reported recent operating losses, a mid-2027 target for Phase 3 results and held $54.8 …
Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) announced a monthly distribution of $0.09 per share payable on August 31, 2026. The fund focuses on energy infrastructure investments, aiming to provide high after-tax returns with regular cash distributions, which are subject to board approval and company financial covenants.
The S&P 500 closed at a record 7,489.72 on Aug 3, 2026, delivering a rolling one-year return of 20.1%. The advance followed a volatile sequence that began in early 2025, featuring a sharp spring selloff, heavy month-to-month swings, a rebound led by mega-cap technology, and intermittent rotation into cyclical sectors. Persistent speculative caution…
Nexera Technologies Ltd announced a letter of intent with Nebo Holdings Limited to become the exclusive worldwide reseller and distributor of Nebo's Preempt OSINT darknet intelligence software, targeting operators of data centers with threat detection services. The agreement, pending a technical proof of concept and due diligence, aims to expand Ne…
Boris Nadezhdin, a 63-year-old former liberal lawmaker and outspoken critic of Russia's war in Ukraine, said he has left Russia and is currently abroad. In a short video posted on Telegram from the Eiffel Tower in Paris, he said he was "alive and free" and would outline his next steps later. His exit follows his inclusion on Russia's "foreign agent…
Helus Pharma announces the appointment of Michael Halstead as CEO to lead the company through critical late-stage clinical development and commercialization phases. Halstead brings 25 years of experience from Intra-Cellular Therapies, including a successful track record in drug development, launch, and commercialization. The company is advancing HL…
High Templar Tech (HTT) trades at a steep discount to book with a market cap of roughly $372M and a P/E around 4.1. With privatization rumors circulating and short interest elevated, a cash‑secured put strategy offers asymmetric reward: collect premium now and either own the stock at an attractive cost basis or walk away with income if the deal nev…
Franklin Resources (BEN) presents a pragmatic long trade over the next 45 trading days. The combination of steady dividend income (yield ~3.9%), visible ETF/mutual fund distribution activity, partnerships expanding digital asset custody/distribution capabilities, and constructive technicals argues for a trade entry around $33.50. Valuation is reaso…
